UNSPSC 51184014: Metahexamide

This classification denotes an anti-diabetic agent with the molecular formula C14H21N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) T3U6F5D722, chemically known as 1,3,5-triazine-2,4-diamine, 6-chloro-n,n,n,n-tetraethyl- but more generally known as metahexamide, which bears US NIH Compound Identifier 11259. European Medicines Agency schedules Metahexamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08803MIG.

UNSPSC 51184014 Metahexamide is a Commodity code representing a specific pharmaceutical active ingredient that state and local governments procure primarily through health department formularies, correctional health programs, and public hospital systems. Metahexamide is a sulfonamide diuretic used in clinical settings for hypertension and edema management, and purchasing under this code reflects acquisition of the drug itself or finished pharmaceutical products containing it as the active ingredient. State and local health authorities, departments of corrections, and county and municipal hospital networks are the primary issuing bodies soliciting under this code, typically through standing pharmaceutical supply contracts or formulary additions that feed centralized dispensing systems.

The source provided contains no recent state or local contract opportunities tagged to UNSPSC 51184014. Without posted solicitations or awarded contracts identifying jurisdictions, response dates, or specific procurements, the geographic distribution and current market activity under this code cannot be characterized from available records. Firms pursuing pharmaceutical supply contracts with state and local health systems should monitor formulary updates and health procurement notices directly from state pharmacy boards and corrections departments rather than relying on this code as a primary search signal.